Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 80 of 114

  1. Protein C Concentrate (Human) Vapor Heated

    Takeda

    Protein C Deficiency

    phase 3 small molecule completed

    1 trial

  2. Prucalopride

    Takeda

    Constipation

    phase 3 small molecule terminated

    1 trial

  3. Psilocybin

    Compass Therapeutics

    Major Depressive Disorder

    phase 3 small molecule active

    2 trials

  4. Psilocybin

    Compass Therapeutics

    Treatment Resistant Depression

    phase 3 small molecule active

    7 trials

  5. Puxitatug Samrotecan

    AstraZeneca

    Endometrial Cancer

    phase 3 small molecule active

    1 trial

  6. QAW039

    Novartis Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  7. QAW039 150 mg

    Novartis Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial

  8. QIVc

    Seqirus (Australia) Pty Ltd

    Influenza, Human

    phase 3 mab completed

    1 trial

  9. QL2107, PEMBROLIZUMAB

    Lacuna Pharma Pty Ltd

    Non-small cell lung cancer

    phase 3 small molecule active

    1 trial

  10. QMF149

    Novartis Pharmaceuticals

    Asthma

    phase 3 small molecule active

    1 trial

  11. QMF149 150/80 μg

    Novartis Pharmaceuticals

    Mild Asthma

    phase 3 small molecule completed

    1 trial

  12. QRX003

    Quoin Pharmaceuticals,

    Netherton Syndrome

    phase 3 small molecule active

    1 trial

  13. QRX003, 4% Lotion

    Quoin Pharmaceuticals,

    Netherton Syndrome

    phase 3 small molecule active

    2 trials

  14. QRX003-2% Lotion

    Quoin Pharmaceuticals,

    Netherton Syndrome

    phase 3 small molecule active

    1 trial

  15. QTORIN 3.9% Rapamycin Anhydrous Gel

    PALVELLA THERAPEUTICS, INC.

    Microcystic Lymphatic Malformation

    phase 3 small molecule active

    1 trial

  16. QTORIN 3.9% rapamycin anhydrous gel

    PALVELLA THERAPEUTICS, INC.

    Pachyonychia Congenita

    phase 3 small molecule completed

    1 trial

  17. QVA149

    Novartis Pharmaceuticals

    Chronic Obstructive Pulmonary Disease (COPD)

    phase 3 small molecule completed

    1 trial

  18. QVM149

    Grace Therapeutics

    Asthma

    phase 3 small molecule terminated

    1 trial

  19. QVM149 150/50/160

    Novartis Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  20. Qarziba 4.5 mg/mL concentrate for solution for infusion

    COLLEGIUM PHARMACEUTICAL, INC

    Recurrent or progression of neuroblastoma or neuroblastoma or neuroblastoma refractory to first-line treatment.

    phase 3 small molecule active

    1 trial

  21. Qing'E pills

    Universal Integrated

    Menopause

    phase 3 small molecule completed

    1 trial

  22. Quadrivalent influenza modRNA vaccine

    Pfizer

    Influenza, Human

    phase 3 mab completed

    1 trial

  23. Quadrivalent influenza vaccine

    Sinovac Research and Development Co.,

    Seasonal Influenza

    phase 3 mab completed

    2 trials

  24. Quadrivalent influenza vaccine(0.25ml)

    Sinovac Research and Development Co.,

    Seasonal Influenza

    phase 3 mab completed

    2 trials

  25. Quemliclustat

    Arcus Biosciences

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 3 small molecule active

    1 trial

  26. Quetiapine SR

    AstraZeneca

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  27. R2810-ONC-16113

    Lacuna Pharma Pty Ltd

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  28. R2810-ONC-1624

    Lacuna Pharma Pty Ltd

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  29. R2810-ONC-1788

    Lacuna Pharma Pty Ltd

    Cutaneous Squamous Cell Carcinoma (CSCC)

    phase 3 small molecule active

    1 trial

  30. R3767-ONC-2011

    Lacuna Pharma Pty Ltd

    Melanoma

    phase 3 small molecule active

    1 trial

  31. R3767-ONC-2235

    Lacuna Pharma Pty Ltd

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  32. R3918-AMD-2326

    Lacuna Pharma Pty Ltd

    Geographic Atrophy Secondary to Age-Related Macular Degeneration

    phase 3 small molecule active

    1 trial

  33. R3918-PNH-2021

    Lacuna Pharma Pty Ltd

    Paroxysmal nocturnal haemoglobinuria (PNH)

    phase 3 small molecule active

    1 trial

  34. R5458-ONC-2246

    Lacuna Pharma Pty Ltd

    Relapsed Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  35. R668-AD-1434

    Lacuna Pharma Pty Ltd

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  36. R668-BP-1902

    Lacuna Pharma Pty Ltd

    Bullous Pemphigoid

    phase 3 small molecule active

    1 trial

  37. R727-CL-1112

    Regeneron UK Limited

    Heterozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    1 trial

  38. R7508-DVT-24116

    Lacuna Pharma Pty Ltd

    Thromboembolic disease

    phase 3 small molecule active

    1 trial

  39. R7508-DVT-24120

    Lacuna Pharma Pty Ltd

    Symptomatic Venous Thromboembolism (VTE)

    phase 3 small molecule active

    1 trial

  40. RA101495-02.302

    Lacuna Pharma Pty Ltd

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  41. RAD001

    Novartis Pharmaceuticals

    Tuberous Sclerosis Complex-associated Refractory Seizures

    phase 3 small molecule completed

    1 trial

  42. RAMIRIS

    The George Institute

    advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctions, who failed prior line of palliative chemotherpay

    phase 3 small molecule active

    1 trial

  43. RAMUCIRUMAB, ERLOTINIB

    Eli Lilly Co.

    Metastatic Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  44. RANOLAZINE, FLECARDIA Διάλυμα για ένεση/έχχυση

    Lacuna Pharma Pty Ltd

    Restoration of sinus rhythm in patients with recent AF onset

    phase 3 small molecule active

    1 trial

  45. RAP-219

    Rapport Therapeutics

    Focal Seizure

    phase 3 small molecule active

    2 trials

  46. RBC transfusion based on different protocols

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Transfusion Related Complication

    phase 3 other active

    1 trial

  47. RBP-6000

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 3 small molecule completed

    4 trials

  48. RBP-7000

    Indivior Pty Ltd

    Schizophrenia

    phase 3 small molecule completed

    5 trials

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.